| Autor: |
Andrea Milani, Imperia Nuzzolese, Giovanna Chilà |
| Jazyk: |
English<br />Italian |
| Rok vydání: |
2018 |
| Předmět: |
|
| Zdroj: |
AboutOpen, Vol 4, Iss 1 (2018) |
| Druh dokumentu: |
article |
| ISSN: |
2465-2628 |
| DOI: |
10.19156/abtpn.2018.0030 |
| Popis: |
Lapatinib is a small molecule and a reversible inhibitor of HER2, which has shown to be effective on brain lesions in patients with HER2-positive breast cancer relapsed at the central nervous system (CNS). We report the clinical case of a young woman, treated with the combination of lapatinib and capecitabine from September 2009 to today for a metastatic recurrence of HER2-positive breast carcinoma at CNS level and who has achieved a complete response of the encephalic lesion and has not shown disease progression at systemic or CNS level, with excellent tolerance profile (Oncology). |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
